In accordance with the present results, previous studies have demonstrated that EIF3B downregulation suppresses cell proliferation, migration and invasion, and induces cell apoptosis by blocking the β-catenin pathway in endometrial cancer [46] or the PI3K/AKT/mTOR pathway in gastric cancer [41]. Here, EIF3B is linked to endometrial cancer.